Clinical Trial Update: Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized trial evaluated dexamethasone for COVID-19-related ARDS but was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Adult

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | Conditions: Respiratory Distress Syndrome, Adult, Covid-19 | Phase 3 | Status: TERMINATED